AMERIPRISE FINANCIAL INC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 124 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2021$1,662,000
-35.2%
180,938
-31.5%
0.00%0.0%
Q1 2021$2,564,000
-2.1%
264,092
+3.4%
0.00%0.0%
Q4 2020$2,619,000
-0.0%
255,309
-1.7%
0.00%0.0%
Q3 2020$2,620,000
+18.8%
259,750
+22.7%
0.00%0.0%
Q2 2020$2,206,000
+59.0%
211,695
+28.7%
0.00%0.0%
Q1 2020$1,387,000
+10.8%
164,521
+15.0%
0.00%0.0%
Q4 2019$1,252,000
-16.0%
143,118
+3.4%
0.00%0.0%
Q3 2019$1,491,000
-5.8%
138,444
+11.1%
0.00%0.0%
Q2 2019$1,583,000
-84.7%
124,605
-53.4%
0.00%
-80.0%
Q1 2019$10,371,000
+48.5%
267,293
-22.1%
0.01%
+66.7%
Q4 2018$6,982,000
-53.2%
343,064
+5.4%
0.00%
-40.0%
Q3 2018$14,924,000
-24.7%
325,565
-2.9%
0.01%
-44.4%
Q2 2018$19,822,000
-29.0%
335,120
-18.3%
0.01%
-30.8%
Q1 2018$27,904,000
-14.0%
410,034
+25.0%
0.01%
-13.3%
Q4 2017$32,428,000
+63.6%
328,063
+98.2%
0.02%
+66.7%
Q3 2017$19,824,000
+38.3%
165,547
+0.9%
0.01%
+28.6%
Q2 2017$14,339,000
+0.4%
164,104
-57.3%
0.01%0.0%
Q1 2017$14,286,000
+19.6%
384,035
-1.3%
0.01%0.0%
Q4 2016$11,948,000
-16.8%
389,183
+81.7%
0.01%
-12.5%
Q3 2016$14,362,000
+2063.0%
214,192
+846.8%
0.01%
Q1 2016$664,000
-59.2%
22,623
+9.0%
0.00%
-100.0%
Q4 2015$1,626,000
-0.9%
20,746
-4.6%
0.00%0.0%
Q3 2015$1,640,000
-50.4%
21,746
-23.3%
0.00%
-50.0%
Q2 2015$3,309,000
-72.0%
28,349
-43.4%
0.00%
-71.4%
Q1 2015$11,822,000
+9.7%
50,077
-12.1%
0.01%
+16.7%
Q4 2014$10,781,000
+2.0%
56,962
+28.6%
0.01%0.0%
Q3 2014$10,565,000
+301.7%
44,285
+11.1%
0.01%
+200.0%
Q2 2014$2,630,000
+907.7%
39,852
+1485.2%
0.00%
Q1 2014$261,000
-47.7%
2,514
-47.9%
0.00%
Q4 2013$499,000
-95.7%
4,824
-97.8%
0.00%
-100.0%
Q3 2013$11,711,000
+110.1%
218,250
+73.7%
0.01%
+100.0%
Q2 2013$5,575,000125,6150.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$5,108,0002.15%
Camber Capital Management LP 4,235,000$12,070,0000.52%
Kynam Capital Management, LP 579,915$1,653,0000.42%
GLOBEFLEX CAPITAL L P 419,322$1,195,0000.29%
Eversept Partners, LP 1,435,077$4,089,9690.29%
ARMISTICE CAPITAL, LLC 1,500,000$4,275,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 506,066$1,442,0000.07%
XTX Topco Ltd 36,130$103,0000.04%
State of Wyoming 20,732$59,0000.04%
Patriot Financial Group Insurance Agency, LLC 55,500$158,0000.03%
View complete list of PUMA BIOTECHNOLOGY INC shareholders